Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Haemophilus Influenzae Infection”

189 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 189 results

Large-scale testing (Phase 3)Study completedNCT00136604
What this trial is testing

Response to GSK Biologicals' Tritanrix-HepB/Hib-MenAC Vacc (4th Dose) at 15-24m & Mencevax ACWY at 24-30m

Who this might be right for
Whole Cell PertussisHaemophilus Influenzae Type bHepatitis B+3 more
GlaxoSmithKline 617
Large-scale testing (Phase 3)Study completedNCT00404651
What this trial is testing

Lot Consistency Study of DTaP-IPV-HB-PRP~T Vaccine Administered at 2-4-6 Months of Age in Healthy Infants

Who this might be right for
DiphtheriaTetanusPertussis+2 more
Sanofi Pasteur, a Sanofi Company 1,189
Post-approval studies (Phase 4)Study completedNCT00153556
What this trial is testing

Study to Eliminate Hib Carriage in Rural Alaska Native Villages

Who this might be right for
Haemophilus Influenzae Type BCarrier State
Centers for Disease Control and Prevention 3,200
Not applicableEnded earlyNCT02972281
What this trial is testing

Systematic Search for Primary Immunodeficiency in Adults With Infections

Who this might be right for
Complement DeficiencyAntibody DeficiencyChronic Sinus Infection+7 more
University Hospital, Lille 120
Not applicableUnknownNCT00932269
What this trial is testing

Seroimmunity 2007 and Sub Study of the Swedish Population Regarding Vaccine Preventable Disease

Who this might be right for
DiphtheriaTetanusPertussis+6 more
Swedish Institute for Infectious Disease Control 5,400
Early research (Phase 1)Study completedNCT01485406
What this trial is testing

Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' Pneumococcal Vaccine 2830930A Administered in Toddlers

Who this might be right for
Infections, Streptococcal
GlaxoSmithKline 61
Testing effectiveness (Phase 2)Study completedNCT00307567
What this trial is testing

Multicentre Booster & Immune Memory Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine or a Single Dose of 23-valent Plain Polysaccharide Vaccine in Healthy Children Aged 11-18 Mths, Previously Vaccinated in Study 103488

Who this might be right for
Acellular PertussisTetanusHepatitis B+3 more
GlaxoSmithKline 689
Large-scale testing (Phase 3)Study completedNCT02139228
What this trial is testing

Persistency Study After Hib-CRM (Cross-Reacting Material)197 or Hib-TT (Tetanus Toxoid) Vaccines in Chinese Children

Who this might be right for
Meningitis, Epiglottitis, Pneumonia, Arthritis Caused by Haemophilus Influenzae Type b
Novartis Vaccines 426
Large-scale testing (Phase 3)Study completedNCT00772928
What this trial is testing

Study of the Effect of Pneumococcal Conjugate Vaccine (PCV) on Immunogenicity of Pentacel™

Who this might be right for
DiphtheriaTetanusHaemophilus Infection+2 more
Sanofi 1,167
Post-approval studies (Phase 4)Study completedNCT01358825
What this trial is testing

Study to Evaluate Antibody Persistence in Children Previously Vaccinated With Infanrix Hexa™ or Infanrix-IPV/Hib™

Who this might be right for
TetanusPoliomyelitisHaemophilus Influenzae Type b+4 more
GlaxoSmithKline 58
Large-scale testing (Phase 3)Study completedNCT01480258
What this trial is testing

Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 4, and 11 to 12 Months (V419-008)

Who this might be right for
Bacterial InfectionsVirus Diseases
MCM Vaccines B.V. 1,315
Large-scale testing (Phase 3)Study completedNCT00891176
What this trial is testing

Persistence of Antibodies at 3, 4 and 6 Years of Age After Vaccination With Meningococcal, Pneumococcal and Hib Vaccines

Who this might be right for
Neisseria MeningitidisHaemophilus Influenzae Type b
GlaxoSmithKline 582
Large-scale testing (Phase 3)Study completedNCT00534833
What this trial is testing

Immunogenicity Study of Antibody Persistence and Booster Effect of DTaP-HB-PRP~T Combined Vaccine or Tritanrix-HepB/Hib™

Who this might be right for
DiphtheriaTetanusPertussis+2 more
Sanofi Pasteur, a Sanofi Company 362
Large-scale testing (Phase 3)Study completedNCT01062477
What this trial is testing

DTaP//PRP-T Combined Vaccine (ACTACEL) Versus Local DTaP and Act-HIB Monovalent Vaccine in Healthy Infants

Who this might be right for
DiphtheriaTetanusPertussis+1 more
Sanofi 1,056
Testing effectiveness (Phase 2)Study completedNCT01061541
What this trial is testing

Immunogenicity, Safety & Reactogenicity of GSK Vaccine Tritanrix™-HepB/Hib2.5 Compared to GSK Vaccine Tritanrix™-HepB/Hiberix™

Who this might be right for
Haemophilus Influenzae Type b
GlaxoSmithKline 192
Large-scale testing (Phase 3)Study completedNCT02074345
What this trial is testing

Phase III Study of Intramuscular TAK-816 in Healthy Infants

Who this might be right for
Healthy VolunteersHaemophilus Influenzae Type b, Prevention
Takeda 31
Large-scale testing (Phase 3)Study completedNCT00483574
What this trial is testing

Study of the Safety of Menactra® Vaccine When Administered With Other Pediatric Vaccines to Healthy Toddlers

Who this might be right for
Meningococcal MeningitisMeaslesMumps+2 more
Sanofi Pasteur, a Sanofi Company 1,378
Not applicableLooking for participantsNCT04664569
What this trial is testing

National Bacterial Meningitis Study

Who this might be right for
MeningitisChildren, OnlyPneumococcal Conjugate Vaccine+5 more
Association Clinique Thérapeutique Infantile du val de Marne 8,230
Large-scale testing (Phase 3)Study completedNCT00453570
What this trial is testing

Immunogenicity and Safety of Pentaxim as 3 Doses Primary Vaccination Followed by a Booster Dose at 18 Months

Who this might be right for
DiphtheriaTetanusHaemophilus Influenzae Type b+2 more
Sanofi 792
Testing effectiveness (Phase 2)Study completedNCT00129116
What this trial is testing

3 Formulations of Hib-MenCY-TT Vaccine & 1 Formulation of Hib-MenC-TT Vaccine Compared to Licensed Meningococcal Serogroup C Conjugate Vaccine, Each Administered at 2,3,4 Mths of Age

Who this might be right for
Haemophilus Influenzae Type bNeisseria Meningitidis
GlaxoSmithKline 388
Load More Results